Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database
about
Current status of active surveillance in prostate cancerManagement of low (favourable)-risk prostate cancerComparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupSerum methionine metabolites are risk factors for metastatic prostate cancer progressionIs active surveillance a suitable option for African American men with prostate cancer? A systemic literature review.Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancerMany young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance.Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy.Does prostate cancer aggressiveness change with increasing age?Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments.Prostate cancer in men of African origin.Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping.Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols.Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance.Oncologic outcomes following radical prostatectomy in the active surveillance era.Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients.The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml.Comparison of pathological outcomes of active surveillance candidates who underwent radical prostatectomy using contemporary protocols at a high-volume Korean center.Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study.High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy.Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes.Expanded criteria for active surveillance in prostate cancer: a review of the current data.Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.Q57133489
P2860
Q26766307-4C7B2087-BFCD-49F4-96FD-29A5EF19F906Q26996501-88CD87E7-61AA-4FED-8296-E31AAAE78CE4Q27011661-536511BD-71C8-41B5-81B1-8C6D1FFC5B4CQ28476490-D3B90F17-DA7F-4365-BCC3-1C559E4B103FQ30234760-96ABEC8D-4D37-454D-8146-11A967C0C681Q33672510-69F84DDD-FCC4-45C7-8E30-481EA2133A89Q34340561-7A79A5DF-CE9D-4260-9DE3-9CAF05CEA149Q36090379-7BF241EC-34C3-41DE-BB46-23CCE286B2D7Q36798276-9072677D-8AB8-472A-95F3-FC9831DD0D39Q37427720-F7B81872-CCBD-49A4-8222-923F6C1A54D9Q37864711-F13C255A-17BF-4CCA-A571-F993F2BA698EQ38373601-B1C34267-0EBA-4C21-9610-D08B43D46A58Q38683379-91E5E523-491D-4B52-ABB7-FFF60ADCF860Q38988252-9BDECD83-F556-46A7-A623-EA68010FF387Q39396694-59DD523F-A23C-48F3-9B9A-7259B89D20B7Q39648538-4D2D62A2-BADD-46EB-825E-8B9F7B99127EQ41992772-5E07F24C-CF9E-4953-A277-C2B875778CDBQ42736742-78A9D71E-E29F-450C-9C43-9034F8C84B2FQ43089360-6F45FFCE-FE03-4A67-ADAD-7F257E4866D6Q43871998-671C0979-BEC1-4313-9D8C-200456136256Q45353776-310B86BA-2B6F-412C-950B-8610988C90DFQ46392150-BF8D8761-05C0-4C1E-A30F-C1F5ADE2AD77Q47171954-CD664751-38CC-459E-B69F-2CE50176F172Q48428320-AF070771-4567-4F21-899E-FAE636B9CFCFQ51721144-6CFB813A-DE02-4C65-B642-62E19F4220CCQ54920929-6A439D8A-D5E3-4EBF-B83E-E81BED4E95E5Q55239741-BE87C382-A3E7-4C5E-9BDD-66108B6C686DQ55279811-2E6758ED-CC6C-4C8C-9CFA-9B2325330681Q57133489-D4CE4E37-75D7-4E86-A405-5E4923256EAA
P2860
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Outcomes after radical prostat ...... sults from the SEARCH database
@ast
Outcomes after radical prostat ...... sults from the SEARCH database
@en
Outcomes after radical prostat ...... sults from the SEARCH database
@nl
type
label
Outcomes after radical prostat ...... sults from the SEARCH database
@ast
Outcomes after radical prostat ...... sults from the SEARCH database
@en
Outcomes after radical prostat ...... sults from the SEARCH database
@nl
prefLabel
Outcomes after radical prostat ...... sults from the SEARCH database
@ast
Outcomes after radical prostat ...... sults from the SEARCH database
@en
Outcomes after radical prostat ...... sults from the SEARCH database
@nl
P2093
P2860
P1433
P1476
Outcomes after radical prostat ...... sults from the SEARCH database
@en
P2093
Christopher J Kane
Christopher L Amling
Joseph C Presti
Martha K Terris
SEARCH Database Study Group
Stephen J Freedland
William J Aronson
P2860
P304
P356
10.1016/J.UROLOGY.2009.12.073
P407
P577
2010-04-15T00:00:00Z